Abstract:Background: Demyelinating diseases in central nervous system (CNS) are a group of diseases characterized by myelin damage or myelin loss. Transforming growth factor beta1 (TGF-β1) is widely recognized as an anti-inflammatory cytokine, which can be produced by both glial and neuronal cells in CNS. However, the effects of TGF-β1 on demyelinating diseases and its underlying mechanisms have not been well investigated. Methods: A demyelinating mouse model using two-point injection of lysophosphatidylcholine (LPC) to the corpus callosum in vivo was established. Exogenous TGF-β1 was delivered to the lesion via brain stereotactic injection. LFB staining, immunofluorescence, and Western blot were applied to examine the severity of demyelination and pyroptosis process in microglia. Morris water maze test was used to assess the cognitive abilities of experimental mice. Furthermore, lipopolysaccharide (LPS) was applied to induce pyroptosis in primary cultured microglia in vitro, to explore potential molecular mechanism. Results: The degree of demyelination in LPC-modeling mice was found improved with supplement of TGF-β1. Besides, TGF-β1 treatment evidently ameliorated the activated proinflammatory pyroptosis of microglia, with downregulated levels of the key pyroptosis effector Gasdermin D (GSDMD), inflammasomes, and cleaved-IL-1β, which effectively attenuated neuroinflammation in vivo. Evaluated by behavioral tests, the cognitive deficit in LPC-modeling mice was found mitigated with application of TGF-β1. Mechanistically, TGF-β1 could reverse pyroptosis-like morphology in LPS-stimulated primary cultured microglia observed by scanning electron microscopy, as well as decrease the protein levels of cleaved-GSDMD, inflammasomes, and cleaved-IL-1β. Activation of ERK1/2 and NF-κB pathways largely abolished the protective effects of TGF-β1, which indicated that TGF-β1 alleviated the pyroptosis possibly via regulating NF-κB/ERK1/2 signal pathways. Conclusions: Our studies demonstrated TGF-β1 notably relieved the demyelinating injury and cognitive disorder in LPC-modeling mice, by attenuating the inflammatory pyroptosis of microglia via ERK1/2 and NF-κB pathways. Targeting TGF-β1 activity might serve as a promising therapeutic strategy in demyelinating diseases.

Transforming Growth Factor-Β1 Induces Apoptosis of Rat Microglia Without Relation to Bcl-2 Oncoprotein Expression

Transforming Growth Factor-Beta 1 (Tgf-Beta 1)-Mediated Inhibition of Glial Cell Proliferation and Down-Regulation of Intercellular Adhesion Molecule-1 (Icam-1) Are Interrupted by Interferon-Gamma (Ifn-Gamma)

2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Induces Microglial Nitric Oxide Production and Subsequent Rat Primary Cortical Neuron Apoptosis Through P38/jnk MAPK Pathway.

Transforming Growth Factor-Beta 1 Increases Bad Phosphorylation and Protects Neurons Against Damage.

Shift from Anti- to Proinflammatory Cytokine Profiles in Microglia Through LPS- or IFN-gamma-mediated Pathways.

The microRNA miR-181c controls microglia-mediated neuronal apoptosis by suppressing tumor necrosis factor

Tgf-Beta 1-Conditioned Glial Cell-Derived Dendritic Cells Inhibit Expansion of Mbp-Reactive T Cells in Vitro

Transforming growth factor-β1 protects mechanically injured cortical murine neurons by reducing trauma-induced autophagy and apoptosis

Neurotrophins Regulate Proliferation and Survival of Two Microglial Cell Lines in Vitro

Molecular Consequences of Activated Microglia in the Brain: Overactivation Induces Apoptosis

Expression of Transforming-Growth-Factor (Tgf)-Beta Receptors and Smad Proteins in Glioblastoma Cell Lines with Distinct Responses to Tgf-Beta 1

Transforming growth factor-β1 regulated phosphorylated AKT and interferon gamma expressions are associated with epithelial cell survival in rhesus macaque colon explants

Transforming growth factor-β1 protects against LPC-induced cognitive deficit by attenuating pyroptosis of microglia via NF-κB/ERK1/2 pathways

Adult microglial TGFβ1 is required for microglia homeostasis via an autocrine mechanism to maintain cognitive function in mice

Transforming growth factor‐β1 protects against white matter injury and reactive astrogliosis via the p38 MAPK pathway in rodent demyelinating model

Transforming growth factor-beta 1 enhances discharge activity of cortical neurons

Microglia mediate non-cell-autonomous cell death of retinal ganglion cells

TGF-β1 protection against Aβ1-42-induced neuroinflammation and neurodegeneration in rats

Retinal neuronal MCP-1 induced by AGEs stimulates TNF-alpha expression in rat microglia via p38, ERK, and NF-kappa B pathways

STAT1-Mediated Down-Regulation of Bcl-2 Expression Is Involved in IFN-γ/TNF-α–Induced Apoptosis in NIT-1 Cells

Smad Protein Mediated Transforming Growth Factor Β1 Induction of Apoptosis in the MDPC-23 Odontoblast-Like Cell Line